MedPath

To study the efficacy of Zinc bio fortified wheat based food in improving low Zinc status in Indian school childre

Not Applicable
Completed
Registration Number
CTRI/2015/06/005913
Lead Sponsor
ETH Eidgenossische Technische Hochschule Zurich
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
270
Inclusion Criteria

zinc deficient otherwise healthy Indian school children

Exclusion Criteria

1. Severe anemia (Hb < 7 g/dl).

2. Consumption of a supplement or dietary supplement containing Zn.

3. Use of drugs that affect the metabolism of Zn, including reducing absorption or increasing excretion; for example tuberculosis medications (ethambutal and isoniazides), drugs used as treatment for entamoeba hystolica (diiodohydroxyquin), drugs that reduce stomach acidity (H2 blockers and proton pump inhibitory), antidepressants (nialamide and isocarboxazid), anti-inflammatory drugs (corticosteroids), diuretics (thiazides), aspirin, penicillamine and alcohol.

4. Suffering from a chronic disease affecting the metabolism of Zn, such as kidney disease or chronic gastrointestinal problems, as for example enter colitis, ulcers and other diseases disturbing the absorption of micro nutrients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Plasma zinc status, C reactive proteins, alpha 1- acid glycoprotein,Timepoint: Baseline <br/ ><br>Mid point ( 1- 5 months) <br/ ><br>endline(6 months) <br/ ><br>Followup (8 months)
Secondary Outcome Measures
NameTimeMethod
Hemoglobin, plasma ferritinTimepoint: Baseline <br/ ><br>Mid point ( 1- 5 months) <br/ ><br>endline(6 months) <br/ ><br>Followup (8 months)
© Copyright 2025. All Rights Reserved by MedPath